- Continue Shopping
- Your Cart is Empty
HITLAB Digital Health Summit 2023 - Hexoskin Video
Our CEO Pierre-Alexandre Fournier presented some of Hexoskin's efforts to solve the evidence gap for healthcare and clinical trials at Columbia University last month, and HITLAB recently made the 15 minutes video available online below.
Clinical evidence is what makes medical discoveries possible: that's how we measure safety and efficacy, and that's how we measure efficiency gains in healthcare delivery. When we lower the cost of evidence, we make care more accessible and affordable. This is an important part of our mission at Hexoskin.
In the video you'll see a few examples of our work at Hexoskin, from clinical research to AI development to human spaceflight.
The Hexoskin and Astroskin platform has been used to collect health data for over 200 scientific publications. White papers about wearable sensors applications for health monitoring of are available upon request.
Hexoskin at HITLAB Digital Health Summit 2023 in New York
Hexoskin's co-founder and CEO, Pierre-Alexandre Fournier, has been invited to speak at the prestigious HITLAB Innovator Summit 2023, hosted at Columbia University in New York City this June 27-29.
In the past 10 years we have seen enormous progress in the use of digital technologies in healthcare to support a wide range of activities: remote care, remote diagnostics, access to medical data, artificial intelligence, virtual clinical trials, genetic analysis, digital biomarker development, molecule discovery, etc. Despite all this progress, patients, physicians, scientists and researchers agree we have barely started to use digital tools to address our growing need for efficient healthcare, therapies and population health management.
The event includes speakers from Merck, Takeda, Pfizer, Syneos, Medidata, CVS, Novo Nordisk, Microsoft, Mount Sinai Health System, Brigham and Women’s Hospital, and many other organizations working to improve human health and access to care.
Please reach out to us if you'd like to arrange a meeting during the event: contact@hexoskin.com
Tickets are still available, and you can get 20% off with the special code SUMMITPAF23.
About Hexoskin
Founded in 2006 in Montreal, Hexoskin is a leader in wearable sensors, software, data science & AI services. The company provides solutions and services to researchers & professionals in pharmaceuticals, academics, healthcare, defense, first responders, space, and aerospace organizations.
Hexoskin's Co-Founder and CEO Pierre-Alexandre Fournier on The Bleeding Edge of Digital Health Podcast
In this episode of the Bleeding Edge of Digital Health, host Mike Moore speaks with entrepreneur, scientist, and co-founder of Hexoskin, Pierre-Alexander Fournier.
Mike and Pierre talk about how his latest tech garment is being utilized in health care today, how it is benefiting not just the patient but the physician as well, and more importantly, the future products and garments in Hexoskin’s pipeline that will pave the way for further innovation and change the way we take care of our health, and the health of the ones we care about. Be sure to listen to the entire session.
Notable Quotes
“So, we're working on different garments. We do have another product that has more sensors called the Astroskin that is being used in research, and that's the product that is being used in the space station right now for different research projects in microgravity. The Astroskin is the model Chris Hemsworth is wearing in Limitless.”
“Research groups we're working with have built the largest database of vital signs for many specific health conditions. So, there are a lot of things that will come out of it. And as I said earlier, we're not just building a product for single use. Eventually, we're going to add blocks to that platform so that it can be used for several types of disease, and it's going to become a great bundle for people with comorbidities.”
Podcast links:
Hexoskin and Halo Health to solve key challenges of clinical trials.
Hexoskin and Halo Health are announcing today a collaboration to solve key challenges in running clinical trials. Combining Hexoskin and Halo Health's technology will offer greater operational efficiency for virtual clinical trials and home monitoring, and offer tools to increase patient engagement.
These new tools will reduce the cost of collecting vital signs data for clinical trials, and will allow patients to participate in medical research from the comfort of their home.
Hexoskin smart garments and its Connected Health Platform are compatible with Halo Health solutions. The two companies will mutually promote their offering to pharmaceutical sponsors to support clinical development.
Halo Health is enabling patient-centric trials to reduce patient and site burden. Its Smart Clinical Trials solution is a digital health platform that provides Remote Patient Monitoring, Patient Engagement, and Workflow Automation. The solution includes an integrated ecosystem of clinical grade sensors and wearables to enable hybrid & virtual trials for various therapeutic areas including cardiology, respiratory and endocrinology.
Pierre-Alexandre Fournier - Chief Executive Officer at Hexoskin: “Medicine's progress depends on being able to better observe patients' outcomes. Anything we can do to lower the cost of data helps accelerate clinical development. This is something that Pharma and Biotech companies need to innovate, but most importantly this is something that we need to do to improve treatments for patients and find new cures for diseases that affect millions of people and their families.” says Pierre-Alexandre Fournier, Chief Executive Officer at Hexoskin. “Combining Halo Health's software with Hexoskin sensors and algorithms reduces the cost of collecting data in clinical trials, with greater flexibility & patient centricity.”
Hexoskin is a pioneer and leader in non-invasive vital signs sensors and remote patient monitoring solutions. Hexoskin Smart Clothing for Men, Women, and Children are clinically validated and its Connected Health Platform is used for health research in cardiology, pulmonology, psychiatry, rare diseases and many other health conditions.
We’re attending #DPHARM2019 in #Boston, at HaloHealth's Kiosk on September 17 & 18, 2019! Visit Booth 30 to learn about our joint innovative solutions to solve the key challenges of Clinical-trials!
Contact Hexoskin to learn more.
Deployment of the Bio-Monitor in Space by Canadian Space Agency Astronaut David Saint-Jacques (CSA)
This week, Canadian Space Agency Astronaut David Saint-Jacques deployed and tested for the first time in space a new Canadian technology: the Bio-Monitor System.
This advanced smart shirt is designed to measure and record vital signs in microgravity environment. It will help keep an eye on astronauts' health and enable medical research in space by continuously measuring physiological data.
The Canadian Space Agency's Bio-Monitor is designed to easily send information to the ground, where scientists can monitor astronauts' physiology around the clock as they orbit the planet. Once operational it will be available for the next five years to all participating countries to the International Space Station.
To learn more: http://asc-csa.gc.ca/eng/missions/expedition58/default.asp.
Photo: CSA/NASA
Columbia University Research Measures Impact of Air Pollution on Cyclists in NYC
Commuting by bike is a great way to include physical activity in our day-to-day living. However the impact of air pollution on cyclists is not something that is well understood.
Columbia University researchers Steven Chillrud, Darby Jack, and their colleagues from the Lamont-Doherty Earth Observatory have been using Hexoskin smart shirts and other sensors to collect data on pollution exposure in a real-world settings. This allows them to map pollution exposure around New York city. These maps can be used by cyclists and policy makers to better plan bike paths and bike lanes.
This project will have an important impact on urban design and mobility. Vice News covered their research project this week in this video:
Live Webinar - Join us on May 30, 2018 at 12PM (EST) for a Live Webinar on Respiratory Monitoring!
The Hexoskin Connected Health Platform is used by researchers in many domains all around the world. Remote & Continuous Respiratory Monitoring is a field of interest that is gaining momentum, but few non-invasive solutions exist to monitor the lung function of subjects and patients.
We invite you to our second webinar that will cover our latest results and applications in respiratory research. We will also present how Hexoskin can monitor COPD patients by using its very unique physiological data.
Webinar: Remote & Continuous Respiratory Monitoring with Hexoskin
30 May 2018, at 12:00 PM (EST) - via the Zoom Video Conferencing software
Speaker: Thu Ngan Trinh, PhD, Clinical Application Specialist at Hexoskin
Guest Speaker: Ruud van Leuteren, MSc, PhD Candidate in Neonatology at the Academic Medical Centre in Amsterdam.
If you are unable to attend, we still invite you to register and we will send you the recorded webinar by email afterward.
We look forward to your presence at this new webinar!
About Hexoskin
Founded in 2006, Hexoskin has designed a system to minimize user setup time and to maximize vital signs monitoring over long periods in a non-obstructive way with sensors embedded in a Smart Shirt. Data are synced to local and remote servers for health data management and analysis. Hexoskin offers a non-invasive solution for longitudinal studies in cardiology, respiratory, sleep, CNS, activity, stress and mental illness.
Meet us at BIO in Boston on June 4-8, 2018!
Hexoskin will be attending the BIO International Convention in Boston, June 4-7, 2018 for its second year! The Smart Clothing industry's leader will present its new clinically validated collection of Smart Garments for clinical research. Hexoskin will also showcase the Hexoskin Smart, the best health monitor for continuous cardiac, respiratory, activity and sleep tracking. Hexoskin will also unveil a new solution to manage clinical trials and report real-world evidence with Machine Learning & AI. Come meet us!
View full article →Fierce Pharma: Pharma has a real-world problem, and it's the lag in its sensor adoption
Adoption of mobile and connected health tech in clinical trials is a real-world challenge for pharmaceutical companies. Our CEO Pierre-Alexandre Fournier has shared his thoughts recently about the adoption of mobile and connected health tech with Fierce Pharma.
"The industry needs to get with it now or pay for it later—literally. The reason? Sensor tech will be adopted faster at a large scale in healthcare than in pharma trials, and that means “the drugs you are developing today are going to be seen with tools that you are not using in your trials right now.” That could cost drugmakers billions of dollars if they launch products only to find that monitoring tech turns up real-world outcomes that don’t meet payers’ standards."
Read more on Fierce Pharma.
Last Year, Erica Wiebe donated her Hexoskin to Museum after winning gold at the Olympics
Erica Wiebe won gold in 75kg Freestyle wrestling in Rio de Janeiro at the 2016 Summer Olympics, and she donates her Hexoskin to the Canada Museum of Sciences and Technology (Ottawa). We are proud to have been part of her physical preparation!
Picture by: Ashley Fraser (Post Media)
She also said in an interview that she will wear her Hexoskin in the next Olympic Games: ''and as I prepare for Tokyo 2020 I'm going to be using it too.''
